Sentry Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
Other funds holding WST
GIM
Sentry Investment Management's WST Position: Q1 2026 in Review
Sentry Investment Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 144 shares — an estimated $40K sold.
Sentry Investment Management first reported a position in WST in Q2 2020 and held it in 22 quarters. The position peaked at $5.81M in Q3 2020. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.
- Sentry Investment Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
- Sentry Investment Management sold 144 West Pharmaceutical shares in Q1 2026, an estimated $40K.
- Sentry Investment Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 22 quarters.
- Sentry Investment Management's West Pharmaceutical position peaked at $5.81M in Q3 2020.
- 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.
Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.